As of 2025-09-18, the Relative Valuation of Magenta Therapeutics Inc (MGTA) is (10.91) USD. This relative valuation is based on P/E multiples. With the latest stock price at 0.70 USD, the upside of Magenta Therapeutics Inc based on Relative Valuation is -1660.1%.
The range of the Relative Valuation is (8.61) - (14.40) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 4.4x - 11.4x | 7.9x |
| Forward P/E multiples | 6.8x - 11.9x | 9.4x |
| Fair Price | (8.61) - (14.40) | (10.91) |
| Upside | -1330.0% - -2158.5% | -1660.1% |
| Date | P/E |